These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24712391)

  • 1. Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer.
    Ma Y; Liu D; Wang D; Wang Y; Fu Q; Fallon JK; Yang X; He Z; Liu F
    Mol Pharm; 2014 Aug; 11(8):2623-30. PubMed ID: 24712391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z
    Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
    Lei M; Ma G; Sha S; Wang X; Feng H; Zhu Y; Du X
    Drug Deliv; 2019 Dec; 26(1):262-272. PubMed ID: 30856352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A personalized and long-acting local therapeutic platform combining photothermal therapy and chemotherapy for the treatment of multidrug-resistant colon tumor.
    Wang B; Wu S; Lin Z; Jiang Y; Chen Y; Chen ZS; Yang X; Gao W
    Int J Nanomedicine; 2018; 13():8411-8427. PubMed ID: 30587968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
    Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
    Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
    Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
    Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
    Zhao D; Zhang H; Yang S; He W; Luan Y
    Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem for targeted delivery of chemotherapeutic agent against multidrug-resistant cancer.
    Luo K; Xu F; Yao T; Zhu J; Yu H; Wang G; Li J
    Int J Biol Macromol; 2021 Jul; 183():1270-1282. PubMed ID: 34004196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L; Xia X; Yang Y; Ye J; Dong W; Ma P; Jin Y; Liu Y
    Int J Pharm; 2016 Nov; 513(1-2):8-16. PubMed ID: 27596118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
    Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
    Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
    Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
    Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis.
    Hu Y; Zhang K; Zhu X; Zheng X; Wang C; Niu X; Jiang T; Ji X; Zhao W; Pang L; Qi Y; Li F; Li L; Xu Z; Gu W; Zou H
    Int J Nanomedicine; 2021; 16():2173-2186. PubMed ID: 33758505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
    Shen J; Yin Q; Chen L; Zhang Z; Li Y
    Biomaterials; 2012 Nov; 33(33):8613-24. PubMed ID: 22910221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer.
    Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y
    Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
    Wang W; Xi M; Duan X; Wang Y; Kong F
    Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
    Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y
    Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
    Mohammad IS; Teng C; Chaurasiya B; Yin L; Wu C; He W
    Int J Pharm; 2019 Feb; 557():304-313. PubMed ID: 30599232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug-resistant tumors significantly.
    Fan Z; Chen C; Pang X; Yu Z; Qi Y; Chen X; Liang H; Fang X; Sha X
    PLoS One; 2015; 10(4):e0120129. PubMed ID: 25831130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor.
    Che L; Liu Z; Wang D; Xu C; Zhang C; Meng J; Zheng J; Yuan H; Zhao G; Zhou X
    Acta Biomater; 2019 Oct; 97():461-473. PubMed ID: 31344512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.